Ghazaleh Tabatabai Selected Research

Ghazaleh Tabatabai Research Topics

Disease

73	Neoplasms (Cancer) 06/2024 - 09/2005
57	Glioma (Gliomas) 03/2024 - 09/2005
55	Glioblastoma (Glioblastoma Multiforme) 07/2024 - 09/2006
16	Meningioma (Meningiomas) 05/2024 - 01/2019
11	Brain Neoplasms (Brain Tumor) 12/2023 - 10/2006
6	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 07/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2013
4	Neurofibromatosis 2 (Neurofibromatosis Type II) 08/2022 - 11/2019
4	Oligodendroglioma 05/2022 - 12/2014
4	Melanoma (Melanoma, Malignant) 02/2020 - 02/2013
4	Hypoxia (Hypoxemia) 09/2015 - 09/2006
3	Necrosis 03/2024 - 02/2022
3	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 11/2019
3	Intellectual Disability (Idiocy) 09/2019 - 01/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2024 - 01/2020
2	Edema (Dropsy) 11/2023 - 01/2022
2	Lymphoma (Lymphomas) 01/2023 - 01/2023
2	Disease Progression 05/2022 - 03/2013
2	Neurilemmoma (Schwannoma) 01/2021 - 11/2019
2	alpha-Thalassemia 09/2019 - 01/2017
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
1	Multiple Sclerosis 12/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2023
1	Genomic Instability 01/2023

Drug/Important Bio-Agent (IBA)

18	Temozolomide (Temodar)FDA LinkGeneric 09/2023 - 09/2006
15	Biomarkers (Surrogate Marker)IBA 06/2024 - 09/2010
15	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2022 - 10/2013
13	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2003
9	Bevacizumab (Avastin)FDA Link 07/2024 - 12/2009
9	MethyltransferasesIBA 07/2024 - 09/2010
8	Messenger RNA (mRNA)IBA 11/2023 - 10/2006
8	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 09/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 02/2007
7	IntegrinsIBA 01/2019 - 12/2009
6	CytokinesIBA 01/2023 - 12/2009
6	Peptides (Polypeptides)IBA 05/2022 - 01/2011
5	Lomustine (CCNU)FDA Link 09/2023 - 12/2014
5	Phosphotransferases (Kinase)IBA 01/2023 - 09/2015
5	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2006
5	Alkylating AgentsIBA 12/2019 - 09/2010
5	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2016 - 10/2008
5	CilengitideIBA 03/2014 - 12/2009
4	ParaffinIBA 07/2023 - 10/2006
4	somatostatin receptor 2IBA 08/2022 - 01/2018
4	AntigensIBA 01/2019 - 01/2015
3	Protein Subunit VaccinesIBA 10/2023 - 01/2021
3	Ganciclovir (Cytovene)FDA LinkGeneric 01/2023 - 01/2022
3	Thymidine KinaseIBA 01/2023 - 01/2022
3	somatostatin receptor type 1IBA 08/2022 - 01/2018
3	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2014
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 11/2018
3	EnzymesIBA 03/2013 - 08/2010
3	Neutralizing AntibodiesIBA 02/2013 - 09/2005
3	CaspasesIBA 02/2011 - 09/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 10/2008 - 09/2005
2	Small Interfering RNA (siRNA)IBA 03/2024 - 08/2010
2	Lysine (L-Lysine)FDA Link 10/2023 - 01/2021
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023 - 01/2018
2	tyrosine receptor (receptor, tyrosine)IBA 01/2023 - 06/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 02/2013
2	larotrectinibIBA 06/2022 - 02/2021
2	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2019
2	alpha-hydroxyglutarateIBA 01/2022 - 10/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2021 - 11/2019
2	VaccinesIBA 01/2021 - 01/2019
2	Histones (Histone)IBA 01/2021 - 01/2016
2	NVP-BKM120IBA 01/2020 - 12/2016
2	regorafenibIBA 12/2019 - 11/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2019 - 01/2018
2	O-(6)-methylguanineIBA 09/2019 - 01/2017
2	InterferonsIBA 03/2019 - 09/2012
2	LigandsIBA 01/2019 - 09/2006
2	ProteomeIBA 01/2019 - 11/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 12/2009
2	NF-kappa B (NF-kB)IBA 01/2018 - 10/2008
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2015
2	Conditioned Culture MediaIBA 12/2016 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 02/2013
2	cyclic arginine-glycine-aspartic acid peptideIBA 02/2013 - 01/2011
2	Angiogenesis InhibitorsIBA 02/2013 - 12/2009
1	boldenone undecylenate (Equipoise)IBA 05/2024
1	sulfur tetrafluorideIBA 11/2023
1	Methionine (L-Methionine)FDA Link 10/2023
1	AcidsIBA 06/2023
1	NucleotidesIBA 01/2023
1	Growth Factor ReceptorsIBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023

Therapy/Procedure

41	Therapeutics 06/2024 - 09/2005
25	Radiotherapy 07/2024 - 02/2007
14	Drug Therapy (Chemotherapy) 01/2023 - 09/2010
7	Immunotherapy 05/2022 - 08/2010
6	Chemoradiotherapy 10/2019 - 09/2010
4	Adjuvant Radiotherapy 07/2023 - 11/2019
3	Precision Medicine 06/2024 - 09/2010
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2021 - 12/2019
2	Intravenous Injections 04/2012 - 06/2010
1	Stem Cell Transplantation 01/2023
1	Aftercare (After-Treatment) 01/2023